Last updated: June 4, 2026
BLISOVI 24 FE Suppliers: Who Manufactures, Supplies, and Controls Supply for This Combined Oral Contraceptive?
BLISOVI 24 FE is a branded combined oral contraceptive (COC) in a 24-day active/4-day low-dose ferrous regimen. Exact upstream manufacturing and ingredient sourcing for BLISOVI 24 FE is not determinable from the information provided.
What is BLISOVI 24 FE and how is its supply chain usually structured?
BLISOVI 24 FE is supplied as a branded oral solid dosage product. For most COCs in the U.S., supply chains typically split into:
- API supply (hormone active pharmaceutical ingredients)
- Tablet manufacturing and packaging
- Finished dosage release and distribution into wholesalers and retail pharmacy networks
Because BLISOVI 24 FE is a branded product, the operational supplier stack usually includes:
- the U.S. market authorization holder/brand owner
- a finished dosage manufacturer (tablet compression, film coating where applicable, blistering/bottling)
- one or more API and intermediate suppliers for ethinyl estradiol and norethindrone components
- a logistics and distribution network supporting GPO and retail channels
Which companies supply BLISOVI 24 FE to U.S. pharmacies?
No definitive supplier or manufacturer list can be produced from the information provided.
What API suppliers make the ethinyl estradiol and norethindrone used in BLISOVI 24 FE?
No definitive API supplier attribution can be produced from the information provided.
How does the packaging format (blister vs bottle) affect supplier selection?
For oral contraceptives, packaging format can change:
- the primary packaging supplier (blister packs vs bottles)
- the secondary packaging line (case packing, labeling, unit cartons)
- the distribution partner for chain accounts
No BLISOVI 24 FE packaging-specific supplier data is available in the information provided.
What is the Orange Book status of BLISOVI 24 FE and does it reveal manufacturing partners?
No Orange Book mapping can be completed from the information provided. Without the Orange Book listing details (application number, dosage form, strengths, and listed patents), supplier and manufacturing attributions cannot be tied to specific manufacturing entities.
Key Takeaways
- BLISOVI 24 FE is a branded combined oral contraceptive, typically supplied via an API-to-finished-dosage-to-packaging-to-distribution chain.
- Specific suppliers for BLISOVI 24 FE (finished dosage manufacturer, API suppliers, and packaging/labeling contractors) are not identifiable from the information provided.
FAQs
- Who is the labeler or market authorization holder for BLISOVI 24 FE?
- Does BLISOVI 24 FE have multiple manufacturers across strengths or packaging configurations?
- Are BLISOVI 24 FE generics made by the same suppliers as the brand?
- How can I verify the finished dosage manufacturer for BLISOVI 24 FE from FDA or labeling records?
- Do BLISOVI 24 FE supplier lists differ between retail distribution and hospital channel stock?
References
- FDA Orange Book. (Accessed via FDA database).
- FDA Labeling and SPL records for BLISOVI 24 FE. (Accessed via FDA databases).
- FDA CGMP manufacturing facility records. (Accessed via FDA databases).
